Occupe actuellement un poste chez Apellis Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chief Innovation Officer | Apellis Pharmaceuticals Inc | 1 avril 2019 - |
Executive Vice President - Research and Development | Apellis Pharmaceuticals Inc | 1 avril 2018 - 1 avril 2019 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2023-09-07 | 2023-09-06 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
1 756
-2.5%
43,0175 526 USD |
1 756 -2.5% | 43,01 | 75 526 USD | |
2022-05-31 | 2022-05-27 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
10 000
-19.9%
43,00430 000 USD |
10 000 -19.9% | 43,00 | 430 000 USD | |
2022-04-06 | 2022-04-05 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
609
-1.2%
60,0936 593 USD |
609 -1.2% | 60,09 | 36 593 USD | |
2022-04-05 | 2022-04-04 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
1 249
-2.3%
57,8172 198 USD |
1 249 -2.3% | 57,81 | 72 198 USD | |
2022-04-05 | 2022-04-04 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
1 437
-2.6%
56,8681 714 USD |
1 437 -2.6% | 56,86 | 81 714 USD | |
2022-04-05 | 2022-04-04 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
818
-1.5%
55,8445 677 USD |
818 -1.5% | 55,84 | 45 677 USD | |
2022-04-04 | 2022-04-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
11 496
-18.0%
55,05632 855 USD |
11 496 -18.0% | 55,05 | 632 855 USD | |
2022-02-14 | 2022-02-11 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
1 666
-3.1%
46,8077 969 USD |
1 666 -3.1% | 46,80 | 77 969 USD | |
2022-02-14 | 2022-02-10 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
10 000
-15.8%
50,00500 000 USD |
10 000 -15.8% | 50,00 | 500 000 USD | |
2022-02-10 | 2022-02-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
10 000
-15.7%
45,00450 000 USD |
10 000 -15.7% | 45,00 | 450 000 USD | |
2022-02-01 | 2022-01-31 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
1 233
-2.2%
38,4747 434 USD |
1 233 -2.2% | 38,47 | 47 434 USD | |
2021-06-11 | 2021-06-10 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
3 417
-11.4%
60,00205 020 USD |
3 417 -11.4% | 60,00 | 205 020 USD |